November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
May 31, 2026 - 00:41
Micron Technology (MU): Renaissance Technologies Is Selling This StockRenaissance Technologies, the quantitative hedge fund known for its data-driven strategies, has been trimming its position in Micron Technology (NASDAQ:MU). The fund first entered the chipmaker`s...
May 30, 2026 - 06:23
Uber Technologies vs. DoorDash: Which Technology Stock Is a Better Buy in 2026?As the gig economy enters a more mature phase, two dominant players are taking very different paths to growth. Uber Technologies has evolved far beyond its ride-hailing roots, building a global...
May 29, 2026 - 20:58
Senior Living CEO Warns of Tech 'Arms Race' and Urges Operational IntegrationThe senior living industry is entering a high-stakes period where technology adoption is no longer optional, according to the CEO of Wellpointe. In a recent address, the executive described the...
May 29, 2026 - 00:13
Blaize to Participate in D.A. Davidson Technology & Consumer ConferenceEL DORADO HILLS, Calif., May 28, 2026 -- Blaize Holdings, Inc., a company focused on programmable and energy-efficient edge AI computing, has announced that its Chief Financial Officer, Harminder...